(4aR,4bS,6aS,7S,9aS,9bS)-4a,6a-Dimethyl-N-(2-methyl-2-propanyl)-2-oxo-2,3,4,4a,4b,5,6,6a,7,8,9,9a,9b,10-tetradecahydro-1H-indeno[5,4-f]quinoline-7-carboxamide(CAS: 166896-74-8)

This compound has a crystalline form with a molecular weight of approximately 612.7 g/mol. It is poorly soluble in water but soluble in organic solvents like ethanol and acetone. Chemically, it is stable under normal conditions but reacts with strong acids and bases. The compound exhibits moderate reactivity towards nucleophiles and electrophiles.

This compound is typically synthesized through multistep organic reactions, including condensation and cyclization. Commonly, a Friedel-Crafts alkylation followed by a Sonogashira coupling reaction is used. The yield is around 50-60%, and the selectivity is high, ensuring a pure product.

This compound is primarily used in the pharmaceutical industry for drug development. It also finds applications in the synthesis of organic materials and in the production of certain sensor technologies. Its unique structure makes it useful in the development of new materials and drug candidates.

Proper PPE, including gloves and safety glasses, should be worn when handling this compound. Work should be conducted in a fume hood to minimize exposure. In case of a spill, it should be cleaned up carefully using appropriate absorbent materials. Always refer to the Safety Data Sheet (SDS) for detailed handling instructions and emergency procedures.